Interleukin-18 (IL-18), for instance, has shown strong associations with systemic activity and MAS development, while calprotectin (S100A8/A9) and S100A12 have been repeatedly linked to systemic flares and poor outcomes [20,21,22]. This evidence concerns the gene IL18 and macrophage activation syndrome.